知乎-W(02390)发布公告，于2025年10月17日，公司根据2022年股份激励计划向若干合资格参与者授出 合共107.98万份受限制股份单位，相当于相同数目的A类普通股及于本公告日期已发行股份总数(不包括 库存股份)的约0.4%(按一股一票基准计算)。惟须待承授人接纳以及遵守2022年股份激励计划的条款及 在其条件达成后方可作实。 ...

于同日，该公司根据2022年第一次股份激励计划的股份奖励而发行1.84万股普通股股份。 达势股份(01405)发布公告，于2025年9月30日，该公司根据2022年首次公开发售前计划的股份期权而发 行1.12万股普通股股份。 ...

小鹏汽车-W(09868)发布公告，于2025年9月25日，根据于2020年6月28日采纳及2020年8月20日获公司股 东批准的2019年股权激励计划以及根据于2025年3月18日采纳及2025年6月27日获公司股东批准的2025年 股份激励计划而发行324.72万股A类普通股以满足限制性股份单位。 ...

哔哩哔哩-W(09626)发布公告，于2025年9月25日，公司根据第二次经修订及重述2018年股份激励计划向 集团151名员工授出合共207.78万份限制性股份单位，代表同等数目的Z类普通股及占于本公告日期公司 已发行股份总数约0.50%(按一股一票基准计算)。 ...

德林控股(01709)公布，于2025年9月22日，陈宁迪先生、DA Wolf及迅昇连同公司决定合共授出1.2亿股 股份，以奖励及激励集团董事、高级管理层及僱员，其中包括将由陈宁迪先生个人及/或透过DA Wolf及 迅昇授出的9000万股股份以及根据2025年受限制股份奖励计划授出的3000万股股份。此外，陈宁迪先生 及陈宁迪先生的配偶江女士已自愿承诺自本公告日期起十二个月内不转让及/或出售彼等持有的任何股 份，展现彼等对集团可持续发展的信心及长期承诺。 于2025年9月22日，陈宁迪先生、DA Wolf及迅昇已决定向集团3名董事及13名高级管理层及僱员合共转 让6000万股股份(占公司于本公告日期已发行股本总额(不包括库存股份)约3.56%)。拟定转让计划于2025 年10月底前完成，以表彰受让人对集团业务及发展所作出的贡献。 此外，公司已获公司控股股东陈宁迪先生告知，陈宁迪先生、DA Wolf及迅昇将于2025年10月底前共同 采纳高管股份奖励计划。 作为初步出资及为表现陈宁迪先生致力在集团培养所有权、激励及问责的企业文化，陈宁迪先生拟直接 及间接转让由陈宁迪先生、DA Wolf及迅昇(或其中任何一方)持 ...

Group 1 - The company, Jiufang Zhitu Holdings (09636.HK), announced that its board has proposed the adoption of the 2025 Share Incentive Plan, pending shareholder approval [1] - The 2025 Share Incentive Plan involves the issuance of new shares, including the transfer of treasury shares, in accordance with Listing Rule Chapter 17 [1] - The implementation of the 2025 Share Incentive Plan is contingent upon receiving approval from the shareholders [1]

Core Viewpoint - The company has proposed a 2025 Share Incentive Plan, which requires shareholder approval to be implemented [1] Group 1 - The board of directors has decided to recommend the adoption of the 2025 Share Incentive Plan on August 28, 2025 [1] - The plan involves the issuance of new shares, including the transfer of treasury shares, as per Listing Rule Chapter 17 [1] - A shareholders' meeting will be convened to seek approval for the adoption of the 2025 Share Incentive Plan [1]

Core Viewpoint - The company, Laopu Gold, experienced a decline in stock price following the announcement of a share reduction by its employee incentive platform, while the controlling shareholders did not participate in the reduction [2] Group 1: Share Reduction and Incentive Plans - Laopu Gold's employee incentive platform reduced its shareholding through block trading, while the controlling shareholders did not reduce their stakes [2] - The company approved several employee share incentive plans, recognizing share-based payment expenses of RMB 28.626 million and RMB 8.633 million for the years 2024 and 2023, respectively [2] Group 2: Financial Performance - In the mid-year report for 2025, Laopu Gold reported revenue of RMB 12.354 billion, a year-on-year increase of 251%, and an adjusted net profit of RMB 2.35 billion, up 290.6% [3] - The growth in revenue and profit is attributed to the expanding brand influence and continuous product optimization, which supported significant revenue growth across both online and offline channels [3] Group 3: Product Pricing and Market Strategy - On August 25, Laopu Gold raised prices for most of its gold jewelry products by 10%-12%, with price increases ranging from RMB 1,000 to RMB 3,000 [3] - The maximum number of H-shares that may be issued under the employee incentive plan is 9.4774 million, representing approximately 5.5% of the total issued shares as of the mid-year report date [3] Group 4: Stock Price Movement - Laopu Gold's stock price has been volatile, previously reaching a high of HKD 1,108 per share on July 8 [4]

Core Viewpoint - Fosun Pharma (600196)(02196) plans to adopt a restricted share unit scheme for H-shares in 2025, aiming to incentivize employees through equity participation [1] Summary by Relevant Sections Share Grant Details - The company intends to grant a total of 10.6964 million restricted share units to 201 eligible employees upon the adoption of the plan, with the specific grant date to be determined by the board [1] - The eligible employees can purchase the corresponding number of H-shares at a price of RMB 1.00 per unit after the restricted share units vest [1] Limitations and Allocations - Due to the cap set by the Hong Kong Stock Exchange on H-share plans, the maximum number of restricted share units that can be granted under this plan is 13.3705 million, which corresponds to 13.3705 million H-shares [1] - This represents approximately 0.5007% of the company's total shares and about 2.4716% of the total H-shares (excluding treasury shares) [1]

Core Viewpoint - 诺诚健华 has announced the initial grant of restricted shares under its 2024 RMB Share Incentive Plan, indicating a commitment to incentivize key personnel and align their interests with shareholders [1] Group 1: Share Incentive Plan - The company granted a total of 9.8702 million restricted shares to 79 incentive recipients, representing approximately 0.56% of the total issued shares as of December 17, 2024 [1] - Following the initial grant, the board has confirmed that the conditions for reserved grants have been met, deciding to grant a total of 2.4676 million restricted shares to 91 incentive recipients on August 20, 2025, which will account for about 0.14% of the total issued shares as of the announcement date [1]